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ABSTRACT  
Background. The precise relation of intestinal gas to symptoms, particularly 
abdominal bloating and distension remains incompletely elucidated. Our aim 
was to define the normal values of intestinal gas volume and distribution and to 
identify abnormalities in relation to functional-type symptoms. 
Methods.  Abdominal CT scans were evaluated in healthy subjects (n=37) and 
in patients in 3 conditions: basal (when they were feeling well; n=88), during an 
episode of abdominal distension (n=82) and after a challenge diet (n=24). 
Intestinal gas content and distribution were measured by an original analysis 
program. Identification of patients outside the normal range was performed by 
machine learning techniques (one-class classifier). Results are expressed as 
median [IQR] or mean±SE, as appropriate. 
Key results. In healthy subjects the gut contained 95 [71, 141] mL gas 
distributed along the entire lumen. No differences were detected between 
patients studied under asymptomatic basal conditions and healthy subjects. 
However, either during a spontaneous bloating episode or once challenged with 
a flatulogenic diet, luminal gas was found to be increased and/or abnormally 
distributed in about one fourth of the patients. These patients detected outside 
the normal range by the classifier exhibited a significantly greater number of 
abnormal features than those within the normal range (3.7±0.4 vs 0.4±0.1; 
p<0.001).  
Conclusions & Inferences. The analysis of a large cohort of subjects using 
original techniques provides unique and heretofore unavailable information on 
the volume and distribution of intestinal gas in normal conditions and in relation 
to functional gastrointestinal symptoms. 
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Key messages  
 Our study, including a relatively large cohort of subjects and applying 
original analysis techniques, provides unique and heretofore unavailable 
information on the volume and distribution of intestinal gas in normal 
conditions and in relation to functional gastrointestinal symptoms. 
 During asymptomatic intervals, patients who complain of gas-related 
symptoms did not show differences in intestinal gas content and 
distribution as compared to healthy subjects. 
 During an episode of abdominal bloating, the same patients exhibited 
relatively minor abnormalities in intestinal gas, but using machine 
learning techniques a significant proportion of them were found outside 
the normal range. 
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INTRODUCTION 
 The volume and distribution of gas within the gastrointestinal tract is 
tightly controlled by a complex homeostasis that involves gas production, 
mucosal absorption, consumption by microbiota, intraluminal propulsion and 
anal evacuation (1). Although patients and physicians frequently attribute 
symptoms, such as abdominal bloating, distension and flatulence, to 
accumulation of gas in the gut, the precise role of gas in this context has not 
been convincingly elucidated (2;3).  
Experimental human studies have shown that, in response to jejunal gas 
infusion, patients with abdominal bloating develop gas retention and symptoms, 
whereas healthy subjects tolerate and rapidly expel the infused gas loads (4-9). 
In apparent conflict with these earlier observations, when such patients 
complaining of abdominal distension were specifically investigated, no major 
abnormalities in intraluminal gas volume and/or distribution were detected either 
during basal conditions or during symptomatic episodes with abdominal 
distension (10-14). However, due to the limited sample size of healthy subjects 
and patients included in previous individual studies, undetected abnormalities 
related to a type II error could not be excluded. 
 The goal of the present study was to define the normal values of 
intestinal gas volume and distribution, and to identify abnormalities in intestinal 
gas in relation to functional-type abdominal symptoms. To this aim, we pooled 
the data from previous studies in healthy subjects and in patients with 
symptoms commonly ascribed to excess intestinal gas, such as bloating, 
abdominal distension and flatulence, performed over the past 10 years in our 
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laboratory under a standard protocol for abdominal CT imaging (10-14). In the 
present study, morphovolumetric analysis techniques previously developed in 
our laboratory have been applied together with new tools specifically developed 
under the current project. Furthermore, taking advantage of the relatively large 
pool of subjects, we applied machine learning techniques to identify patients out 
of the normal range as defined in healthy subjects. 
 
MATERIAL AND METHODS 
Participants  
Groups of patients (see Experimental design below) complaining of 
bloating, abdominal distension, and flatulence were included in the study and 
compared to healthy individuals with no gastrointestinal complaints. All 
participants had filled-out a digestive symptoms questionnaire based on Rome 
criteria; this information was used to establish a diagnosis in patients and to 
verify the absence of symptoms in healthy subjects. The protocols of the 
different studies had been approved by the Institutional Review Board of the 
University Hospital Vall d’Hebron and all subjects gave their written informed 
consent to participate in the studies. 
 
 
CT scanning   
Abdominal CT scans were obtained with a helical multislice CT scanner, 
exposure 120 kV and 50 mAs, using the available dose reduction options (tube 
current modulation). Section thickness and image reconstruction depended on 
the scanner model (2.5-mm thickness, 1.6-mm interval reconstruction with 
Mx8000, Philips Medical Systems, Best, The Netherlands; 2-mm thickness, 1.5-
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mm interval reconstruction with Somatom Sensation 16 or Somatom Definition 
AS, Siemens Medical Solutions, Forchheim, Germany). Images were obtained 
in the supine position during a single breath-hold. No oral or intravenous 
contrast medium was administered. At the time of each CT scan, the 
participant’s subjective sensation of abdominal distension was measured on a 
graphic rating scale graded from 0 (no distension) to 6 (extremely severe 
distension).  
 
Experimental design 
 All participants underwent at least one abdominal CT scan.  A group of 
patients with episodic abdominal distension, i.e. severe distension episodes in 
contrast to mild or no distension during basal conditions, were studied on two 
different symptoms status (paired studies): at baseline when they felt their 
abdomen showed minimal or no distension and during a spontaneous episode 
of severe distension. Another group of patients with the primary complain of 
flatulence, but also affected by bloating and other abdominal symptoms, was 
studied after a challenge diet; in them imaging was performed after a 3-day 
high- flatulogenic diet and 6-h after ingestion of a test meal. The diet included 3 
daily portions of the following: a) bread, cereals and pastries made of whole 
wheat or corn; b) beans, soya bean, corn, broad bean, peas; c) Brussels’ 
sprouts, cauliflower, broccoli, cabbage, celery, onion, leek, garlic, artichoke; and 
d) banana, fig, peach, grapes, prunes. The test meal consisted in cooked beans 
with sausage, whole wheat bread and canned peach. CT scanning and 
analyses were performed blindly, with the investigator unaware of the condition 
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(patient or healthy subject) and the symptom status (basal or symptomatic) of 
the participants.  
 
Data analysis 
Morphovolumetric analysis of CT images was performed using an 
original software program specifically developed in our laboratory and 
previously described in detail (11;15). To measure the volume of gas within the 
gut, images were filtered with a user-defined threshold to separate gas from 
tissues. The program allows measurement of total gas volume within the 
abdominal cavity and of the segmental volumes corresponding to selected 
regions of the gut. For this study two new tools were developed for measuring 
the distribution of gas within the entire small bowel (bubble size and number) 
and in the region potentially corresponding to the terminal ileum (defined as an 
antero-posterior cylinder with a diameter equivalent to ¼ the distance between 
the anterior iliac spines and tangential to the ileocecal valve). 
The software used in this study was built with two open-source toolkits: 
the Insight Segmentation and Registration toolkit (16) and the Visualization 
toolkit, both used for 3D computer graphics, image processing and visualization 
(17). 
 
Statistical analysis   
Statistical analysis was performed using the SPSS 18.0 statistical 
package. Mean ± SE or median values and interquartile range [IQR] of the 
features measured were calculated in each group of subjects, as appropriate. 
The normal range for the different features measured was established by the 5-
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95% of the values in healthy subjects. The Kolmogorov-Smirnov test was used 
to check the normality of data distribution.  Parametric normally-distributed data 
were compared by Student’s t-test for paired or unpaired data; otherwise, the 
Wilcoxon signed rank test was used for paired data and the Mann-Whitney U 
test for unpaired data. Distribution of abnormalities between groups was 
evaluated by the chi-square test. The effect of age and BMI was analyzed by 
dividing the subjects (within subgroups and the whole group) in the two halves 
based on the values of these features and comparing the data of the upper 
versus the lower half. Differences were considered significant at a p value < 
0.05. 
 
 
Algorithm for identification of patients with abnormal intestinal gas 
distribution 
 Each subject was defined by 8 features (dimensions) related to the 
volume of gas in the different gut compartments (Figures 1 and 2). Based on 
the data in healthy subjects, used as a training set, a program (one-class 
support vector machine) calculated the function that best defined the normal 
range allowing 5 % outliers: based on the examples of the training set, the 
program draws the hyperplane that defines the normal range in a 
multidimensional space. In essence, the program instead of defining cut-offs for 
each individual feature, finds the combination of features that best characterizes 
the normal range and constructs the function that defines the boundary plane 
(18). Using this algorithm, the different subgroups of patients were then tested 
to identify those outside the normal range. 
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 Patients identified as abnormal were then analyzed by the K-means 
clustering technique (Lloyd’s algorithm) to determine the existence of subgroups 
(19). This algorithm uses an iterative refinement technique: starting from 
randomly selected subgroups, each case is assigned to the subgroup with the 
nearest mean (centroid of the cluster), and the new mean is calculated; the 
procedure is repeated until convergence is reached. 
Cross validation of the algorithm in the group of healthy subjects, initially 
used as the training set, was performed by partitioning the data sample into 2 
subsets: one was used for training (training set) and the other was then tested 
(validation test set). Specifically, using the leave-one-out method (20), one 
subject from the original data sample was retained as the testing set, and the 
remainder (all but himself) were used as the training set; the procedure was 
repeated for all subjects to define the outliers. 
 
RESULTS 
Healthy subjects 
 In healthy subjects (n = 37; 27 women, 10 men; age range 19-62 years) 
the abdomen contained a median of 95 [71,141] mL gas, which was distributed 
throughout the digestive tract from the stomach down to the pelvic colon, but 
overall the largest part (69 [58, 83] %) was located within the colon (Figures 1 
and 2).  In two healthy subjects the total volume of gas was well above the rest, 
owing to larger colonic gas content.  
In 11 subjects imaging was performed during the postprandial period 
(less than 2 h after ingestion of a meal), and in them gas volume and 
distribution was not different than in another 26 subjects studied during fasting 
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(more than 2-h after ingestion of the last meal). Hence, the whole set of healthy 
subjects was included as training set to develop a classifier, that defined the 
normal range based on the combination of all the features analyzed (total and 
segmental gas content). Cross-validation by the leave-one-out method identified 
2 outliers that fell out of the normal range (Figure 3), which were the two 
subjects with excessive colonic gas content mentioned earlier. 
 
Patients 
All patients were diagnosed as having functional disorders based on 
Rome III criteria (21), 44 of them as functional bloating (9.8±0.8 bowel 
movement/wk, 4.1±0.2 score on the Bristol stool form scale), 52 constipation-
predominant IBS (1.5±0.2 bowel movements/wk, 2.3±0.3 Bristol score); 17 with 
alternating IBS (9.0±2.6 bowel movements/wk, 3.4±0.3 Bristol score), 4 with 
functional abdominal pain (7.0±0.0 bowel movements/wk, 4.1±0.3 Bristol score) 
and 1 diarrhea-predominant IBS.  
 
Basal conditions 
Patients complaining of episodic abdominal distension studied during 
basal conditions (n=88; 82 women, 6 men; age range 19-74 yrs; mean 
abdominal symptom score 2.0±0.2) exhibited a gas pattern (volume and 
distribution) similar as in healthy subjects (Figures 1 and 2). Overall, the number 
of individual features outside the normal range (defined as 5-95 percentile in 
healthy subjects) was not significantly different than in healthy subjects (0.4±0.1 
vs 0.4±0.2; p=0.955). The proportion of patients identified by the classifier 
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outside the normal range was also similar to that of outliers identified by cross-
validation in healthy subjects (Figure 3). 
 
Spontaneous bloating episodes 
 A subset of these patients with episodic abdominal distension (n=82; 77 
women, 5 men; age range 19-74 yrs) were re-evaluated during an episode of 
perceived abdominal distension (4.7±0.1 subjective distension score; p<0.001 
vs basal) and the CT scan showed a modest, but significant, increase in 
abdominal gas as compared to their basal values. The increment was by-and-
large located in the colon (Figures 1 and 2). Overall, the number of individual 
features related to gas volume and distribution outside the normal range 
(1.1±0.2) was significantly greater than during basal conditions (p<0.001) by 
paired analysis) and than in the group of healthy subjects (p=0.042). Using the 
classifier, a significantly greater proportion of patients during an episode of 
spontaneous distension fell outside the normal range (Figure 3).  
 
Challenge diet 
 After the challenge diet, patients that complained of excessive flatulence 
and bloating (n=24; 14 women, 10 men; age range 35-73 yrs) reported 
increased sensation of abdominal distension (4.4±0.2 score vs 3.4±0.3 score 
before challenge; p=0.001). The pattern of intestinal gas on the challenge diet 
resembled that observed in patients during a spontaneous episode of 
abdominal distension, except for a slightly larger accumulation of gas in the 
pelvic colon (Figures 1 and 2). The number of individual features outside the 
normal range (1.1±0.3), as well as the proportion of patients detected as 
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abnormal by the classifier on the challenge diet was not significantly different 
than in patients during spontaneous distension (Figure 3).  
 
Gas distribution within the small bowel  
A further in depth analysis was performed by measuring intraluminal gas 
distribution in the small bowel. In healthy subjects the majority of gas within the 
small bowel was dispersed in bubbles of a wide size range (median volume of 
0.08 [0.06, 0.09] mL) and a small proportion of that gas (15.1 [4.5, 24.8] %) was 
located in an area approximately corresponding to the terminal ileum. The 
spectrum of gas distribution, in terms of bubble size and number of gas bubbles 
either in the entire small bowel or in the region of the terminal ileum did not 
show consistent differences among healthy subjects and the 3 clinical 
conditions in patients (baseline, distension episodes and challenge diet) (Figure 
4).   
 
Characterization of patients identified out of the normal range. 
Patients identified by the classifier outside the normal range, either 
during episodes of spontaneous distension or after the challenge diet, exhibited 
a large number of abnormal features (Figure 3), but no distinctive features or 
specific clusters were identified and their reported distension score (4.7±0.2) 
was similar as in the rest (4.6±0.1). Total gas volume measured in these 
patients with an abnormal gas pattern was 331 [251,384] mL and in 17 out of 
the 21 patients it was above the normal range (Figure 5). No consistent 
differences in intestinal gas volume and distribution were detected in relation to 
age, sex or BMI (data not shown). 
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DISCUSSION  
Our study, applying original analysis techniques on a relatively large 
cohort of subjects, provides unique and heretofore unavailable information on 
the volume and distribution of intestinal gas in normal conditions and in relation 
to functional gut symptoms. 
We took advantage of the standardized acquisition procedure of CT 
imaging in our research program, that has been systematically applied over the 
past 10 years to pool a relatively large sample of patients with symptoms 
commonly attributed to excess gas production or accumulation in the gut lumen, 
such as bloating, abdominal distension and flatulence. This large cohort allowed 
the application of a sophisticated analysis approach by machine learning 
techniques. Provided with sufficient training data, the program learns to identify 
the combination of features, not necessarily abnormal if considered separately, 
that identify individuals outside the normal range.  
During basal conditions, when patients were not experiencing symptoms, 
essentially no abnormalities were detected. Characteristically, bloating and 
abdominal distension often manifest as discrete, relatively brief and transient 
episodes. A key strategy in our program is the ability to acquire CT images on 
demand, and this approach allowed us to show that abnormal gas patterns 
develop in the symptomatic phase in a significant proportion of the same 
patients with normal gas features when asymptomatic. These observations 
further indicate that the content and distribution of gas in the human gut is very 
dynamic and that changes may keep a temporal relation to the occurrence of 
symptoms. Interestingly, the proportion of abnormalities detected during 
symptomatic episodes was similar to that observed in the subgroup of flatulent 
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patients whose symptoms were exacerbated by a challenge diet, the only 
difference being a larger content of gas in the distal colon of the latter. A 
previous paired study in healthy subjects had shown a predominant 
accumulation of gas in the distal gut during the postprandial period (15), in 
analogy to the findings in patients on the challenge diet that were scanned after 
the test meal. 
Conversely, it is intriguing that quite a large proportion of patients, even 
during symptomatic episodes, had showed an apparently normal pattern of 
intestinal gas. It has been consistently shown that patients with functional gut 
disorders complaining of episodic abdominal distension, even during basal 
conditions (i.e. when they are feeling well), manifest impaired transit and 
clearance of exogenous gas directly infused into the jejunum and develop 
symptoms in response to gas loads that are well tolerated by healthy subjects 
(4-9). Abnormalities in intestinal motor function have been also evidenced by 
endoluminal image analysis based on capsule endoscopy (22). This apparent 
discrepancy between prior data on abnormal motor function and normal gas 
content observed in part of our patient sample may be related to different 
factors. First, we acknowledge that in spite of the methodological refinements 
introduced in the present study, our imaging technique may remain insufficiently 
sensitive to detect some subtle abnormalities. Second, impaired gas transit 
evidenced by jejunal infusion studies concerns predominantly the small bowel, 
whereas gas is mostly produced in the colon. Third, the rate of gas infusion 
employed in the experimental studies was much higher than the normal 
production, since the objective was to evaluate the responses to a gas 
challenge. Furthermore, the gas mixture in previous studies mimicked the 
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concentration of gases in venous blood to minimize absorption, and hence, 
contained a large proportion of nitrogen which, in contrast to the gases normally 
produced in the colon (CO2 and hydrogen) is poorly absorbed and metabolized 
by colonic microbiota. Slow transit of endogenous gases would increase their 
absorption and consumption, and thereby reduce intraluminal volume (1;23).  
In this paper, we present results that may be interpreted as consistent 
with the hypothesis that episodic and postprandial increases in intestinal gas 
are pathogenically related to certain functional gut symptoms. However, the 
relatively small magnitude of the changes and the fact that are only observed in 
part of the patient cohort, suggests that other key factors are involved. Indeed, it 
has been well documented that patients with functional gut symptoms manifest 
intestinal hypersensitivity that makes them more susceptible to distension and 
to other intraluminal stimuli (24-26). Specifically, patients complaining of 
abdominal bloating and distension have a poor tolerance of colonic gas loads 
administered transrectally compared to healthy subjects, and develop subjective 
symptoms as well as visible abdominal distension (27;28). The latter is a 
behavioral somatic response of the abdomino-thoracic muscles with a 
paradoxical contraction/descent of the diaphragm (27;28). Thus, we speculate 
that hypersensitive or hypervigilant patients may develop this type of aberrant 
responses to minor alterations or even normal gas content in the gut. Moreover, 
not only gas, but other components of intestinal content could contribute to the 
symptoms that patients may misinterpret as excess gas. The situation is 
distinctively different in patients with intestinal neuropathy and dysmotility 
evidenced by manometry, where the motor dysfunction is associated with 
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massive pooling of intestinal gas and content that produces both abdominal 
distension and abdominal pain (12). 
 In conclusion, a sensitive and precise technology is now available to 
quantify intraluminal gas and its anatomic location. This information may be 
useful in a clinical setting where symptoms are related to excess gas in the gut 
by patients, attending physician or both. If little or no gas is demonstrated, 
evidence for distorted abdomino-thoracic muscular rearrangement as a cause 
for distension may be simultaneously obtained. 
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FIGURE LEGENDS 
 
Figure 1.  Total abdominal and colonic gas content. Data are shown as 
boxplots in healthy subjects and in patients with various 
symptomatic states. 
 
Figure 2. Gas content in different gut compartments. Data are shown as 
boxplots in healthy subjects and in patients with various 
symptomatic states. 
 
Figure 3. Proportion of subjects identified by the classifier within and without 
the normal range (upper panel) and their number of abnormal 
features (lower panel). 
 
Figure 4 Gas in the small bowel: distribution by bubble size. Bubbles are 
pooled by their size in three groups. Data are shown as boxplots in 
healthy subjects and in patients with various symptomatic states. 
 
Figure 5 Examples of abdominal gas. Three-dimensional reconstruction 
from CT scans in a healthy subject (70 mL total volume, 47 mL in 
colon) and a patient outside the normal range (383 mL total 
volume, 363 mL in colon). 
 
